Australian Clinical Labs shares jump as shareholders back AGM resolutions
ACL: $3.15 +6.42% · MC: $619M
Australian Clinical Labs shares jumped about 7% to $3.17 in afternoon trading as shareholders approved all resolutions at the pathology provider’s annual meeting. The vote included the appointment of Deloitte as auditor, performance rights for chief executive Greg Horan and renewal of proportional takeover provisions.
Separate substantial-holder notices showed Commonwealth Bank of Australia’s voting power fell to about 7% from over 8%, while Superannuation and Investments HoldCo reported a similar decline. The notices describe overlapping relevant interests, including interests held through a superannuation trustee and a managed investment scheme; the supplied excerpts do not establish the transactions behind the changes.

Comments